Cargando…
Vitamin D and COVID-19
Epidemiological data report that several countries with a high prevalence of hypovitaminosis D may have increased susceptibility to complications and mortality due to COVID-19 infection. These reports, however, have limitations given that they derive from observational studies. Nevertheless, while a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360122/ https://www.ncbi.nlm.nih.gov/pubmed/32666357 http://dx.doi.org/10.1007/s42000-020-00231-9 |
_version_ | 1783559168639107072 |
---|---|
author | Trovas, George Tournis, Symeon |
author_facet | Trovas, George Tournis, Symeon |
author_sort | Trovas, George |
collection | PubMed |
description | Epidemiological data report that several countries with a high prevalence of hypovitaminosis D may have increased susceptibility to complications and mortality due to COVID-19 infection. These reports, however, have limitations given that they derive from observational studies. Nevertheless, while awaiting more robust data, clinicians should treat patients with vitamin D deficiency irrespective of whether or not it has a link with respiratory infections. |
format | Online Article Text |
id | pubmed-7360122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-73601222020-07-15 Vitamin D and COVID-19 Trovas, George Tournis, Symeon Hormones (Athens) Commentary Epidemiological data report that several countries with a high prevalence of hypovitaminosis D may have increased susceptibility to complications and mortality due to COVID-19 infection. These reports, however, have limitations given that they derive from observational studies. Nevertheless, while awaiting more robust data, clinicians should treat patients with vitamin D deficiency irrespective of whether or not it has a link with respiratory infections. Springer International Publishing 2020-07-14 2021 /pmc/articles/PMC7360122/ /pubmed/32666357 http://dx.doi.org/10.1007/s42000-020-00231-9 Text en © Hellenic Endocrine Society 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Commentary Trovas, George Tournis, Symeon Vitamin D and COVID-19 |
title | Vitamin D and COVID-19 |
title_full | Vitamin D and COVID-19 |
title_fullStr | Vitamin D and COVID-19 |
title_full_unstemmed | Vitamin D and COVID-19 |
title_short | Vitamin D and COVID-19 |
title_sort | vitamin d and covid-19 |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360122/ https://www.ncbi.nlm.nih.gov/pubmed/32666357 http://dx.doi.org/10.1007/s42000-020-00231-9 |
work_keys_str_mv | AT trovasgeorge vitamindandcovid19 AT tournissymeon vitamindandcovid19 |